Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-8,202
Closed -$1.08M – 1014
2025
Q1
$1.08M Buy
8,202
+3,070
+60% +$428K 0.02% 413
2024
Q4
$703K Buy
5,132
+2,753
+116% +$378K 0.01% 506
2024
Q3
$241K Sell
2,379
-13,006
-85% -$1.03M 0.01% 714
2024
Q2
$1.13M Buy
15,385
+3,310
+27% +$217K 0.02% 427
2024
Q1
$611K Sell
12,075
-4,679
-28% -$219K 0.01% 636
2023
Q4
$785K Buy
16,754
+1,233
+8% +$56.2K 0.01% 524
2023
Q3
$708K Buy
+15,521
New +$641K 0.01% 506
2021
Q1
– Sell
-11,257
Closed -$500K – 852
2020
Q4
$500K Buy
+11,257
New +$505K 0.02% 484
2017
Q1
– Sell
-7,804
Closed -$550K – 634
2016
Q4
$550K Buy
+7,804
New +$487K 0.02% 537

Other funds holding AGX

Quadrature Capital's AGX Position: Q2 2025 in Review

Quadrature Capital sold out of Argan (AGX) in Q2 2025, closing a stake of 8,202 shares — an estimated $1.08M sold.

Quadrature Capital first reported a position in AGX in Q4 2016 and held it in 9 quarters. The position peaked at $1.13M in Q2 2024. 355 funds tracked by Wall St. Rank hold AGX as of Q2 2025.

  • Quadrature Capital reported no remaining Argan position as of Q2 2025 after selling out during the quarter.
  • Quadrature Capital sold 8,202 Argan shares in Q2 2025, an estimated $1.08M.
  • Quadrature Capital first reported a position in Argan in Q4 2016 and held it in 9 quarters.
  • Quadrature Capital's Argan position peaked at $1.13M in Q2 2024.
  • 355 funds tracked by Wall St. Rank held Argan as of Q2 2025.

Based on Quadrature Capital's 13F filing for Q2 2025, filed 13 Aug 2025.